<code id='E6BB62229D'></code><style id='E6BB62229D'></style>
    • <acronym id='E6BB62229D'></acronym>
      <center id='E6BB62229D'><center id='E6BB62229D'><tfoot id='E6BB62229D'></tfoot></center><abbr id='E6BB62229D'><dir id='E6BB62229D'><tfoot id='E6BB62229D'></tfoot><noframes id='E6BB62229D'>

    • <optgroup id='E6BB62229D'><strike id='E6BB62229D'><sup id='E6BB62229D'></sup></strike><code id='E6BB62229D'></code></optgroup>
        1. <b id='E6BB62229D'><label id='E6BB62229D'><select id='E6BB62229D'><dt id='E6BB62229D'><span id='E6BB62229D'></span></dt></select></label></b><u id='E6BB62229D'></u>
          <i id='E6BB62229D'><strike id='E6BB62229D'><tt id='E6BB62229D'><pre id='E6BB62229D'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:76
          glum Benjamin — health insurance coverage from STAT
          Adobe

          Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public within the past two years. All three used their stage time at the J.P. Morgan Healthcare Conference to make the case that their drastic decisions — like fully exiting some insurance markets — will deliver the profitability investors are demanding.

          “Insurance company profitability is the number one goal,” Oscar CEO Mario Schlosser said in an interview with STAT in San Francisco.

          advertisement

          “We are actually absolutely focused on profitability right now,” Clover CEO Andrew Toy said during his presentation on Wednesday.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Pharma’s losing bet in New Jersey
          Pharma’s losing bet in New Jersey

          PfizerCEOAlbertBourlawasoneofafewpharmaceuticalexecutiveswhodonatedtoafailedSenatecampaigninNewJerse

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Is mRNA technology the right fit for flu shots? Experts aren’t so sure

          MollyFergusonforSTATHerearetwothingsthataretrue.Theworldneedsmoreeffectivefluvaccines.Andpharmaceuti